132 related articles for article (PubMed ID: 7262161)
21. Etoposide and etoposide-ifosfamide therapy for refractory testicular tumors.
Bremer K; Niederle N; Krischke W; Higi M; Scheulen ME; Schmidt CG; Seeber S
Cancer Treat Rev; 1982 Jun; 9 Suppl():79-84. PubMed ID: 7127338
[No Abstract] [Full Text] [Related]
22. Epipodophyllin derivative (VP 16-213) in treatment of solid tumours.
Cavalli F; Sonntag RW; Brunner KW
Lancet; 1977 Aug; 2(8033):362. PubMed ID: 69974
[No Abstract] [Full Text] [Related]
23. [A phase II study of NK171 (etoposide)].
Kimura K; Niitani H
Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
[TBL] [Abstract][Full Text] [Related]
24. Phase II clinical trial of VP-16-213 in ovarian cancer.
Maskens AP; Armand JP; Lacave AJ; De Jager RL; Hansen HH; Wolff JP
Cancer Treat Rep; 1981; 65(3-4):329-30. PubMed ID: 7016320
[No Abstract] [Full Text] [Related]
25. Epipodophylin derivative (VP 16-23) in malignant teratomas and choriocarcinomas.
Newlands ES; Bagshawe KD
Lancet; 1977 Jul; 2(8028):87. PubMed ID: 69168
[No Abstract] [Full Text] [Related]
26. Reversal of recurrent laryngeal nerve palsy following VP16-213 combination therapy in a patient with metastatic teratoma of the testis.
Rubery ED
Cancer Chemother Pharmacol; 1982; 7(2-3):219-21. PubMed ID: 6177438
[TBL] [Abstract][Full Text] [Related]
27. [A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
Kado M; Oshima S; Matsui Y; Shimokata K; Hara K; Kanda T; Shima K; Takenaka S
Gan To Kagaku Ryoho; 1986 Jan; 13(1):116-21. PubMed ID: 3002282
[TBL] [Abstract][Full Text] [Related]
28. Phase I trial of a new form of an oral administration of VP-16-213.
Lau ME; Hansen HH; Nissen NI; Pedersen H
Cancer Treat Rep; 1979 Mar; 63(3):485-7. PubMed ID: 371801
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial of vindesine in patients with germ-cell tumors.
Reynolds TF; Vugrin D; Cvitkovic E; Gralla RJ; Young CW; Golbey RB
Cancer Treat Rep; 1979 Aug; 63(8):1399-401. PubMed ID: 476713
[No Abstract] [Full Text] [Related]
30. Phase II study of oral VP-16-213 in hepatocellular carcinoma.
Cavalli F; Rozencweig M; Renard J; Goldhirsch A; Hansen HH
Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1079-82. PubMed ID: 6279406
[No Abstract] [Full Text] [Related]
31. Etoposide salvage therapy for refractory germ cell tumors: an update.
Williams SD; Einhorn LH
Cancer Treat Rev; 1982 Jun; 9 Suppl():67-71. PubMed ID: 6290056
[No Abstract] [Full Text] [Related]
32. [Phase II study of etoposide (NK 171) in advanced hematological malignancies].
Yoshida T; Nakanishi J; Ito K; Kobayashi S; Ohtake S; Nakamura S; Hattori K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1579-84. PubMed ID: 6476835
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of etoposide in advanced prostate cancer.
Trump DL; Loprinzi CL
Cancer Treat Rep; 1984 Sep; 68(9):1195-6. PubMed ID: 6478456
[No Abstract] [Full Text] [Related]
34. [A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].
Wakui A; Yokoyama M; Takahashi H; Yoshida Y; Sakata Y; Sato S; Kano A; Kawamoto K; Hashimoto S; Konno K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):319-29. PubMed ID: 3947109
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of etoposide in the treatment of esophageal carcinoma.
Coonley CJ; Bains M; Heelan R; Dukeman M; Kelsen DP
Cancer Treat Rep; 1983 Apr; 67(4):397-8. PubMed ID: 6850656
[No Abstract] [Full Text] [Related]
36. Phase II evaluation of VP-16-213 (NSC-141540) in patients with advanced ovarian carcinoma resistant to alkylating agents.
Edmonson JH; Decker DG; Malkasian GD; Webb MJ; Jorgensen EO
Gynecol Oncol; 1978 Feb; 6(1):7-9. PubMed ID: 620951
[No Abstract] [Full Text] [Related]
37. [Phase I study of an oral administration of VP 16-213].
Ogawa M; Ota K; Oyama A; Fukuoka M; Takada M; Yoshida S; Sanpi K; Kimura I; Ohnoshi T; Kuraishi Y
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2403-7. PubMed ID: 6639102
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.
Schell FC; Yap HY; Hortobagyi GN; Issell B; Esparza L
Cancer Chemother Pharmacol; 1982; 7(2-3):223-5. PubMed ID: 7083463
[No Abstract] [Full Text] [Related]
39. Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.
Kelsen DP; Magill GB; Cheng E; Dukeman M; Sordillo P; Heelan R; Yagoda A
Cancer Treat Rep; 1983 May; 67(5):509-10. PubMed ID: 6850667
[No Abstract] [Full Text] [Related]
40. Treatment of small cell anaplastic carcinoma of the lung with the oral solution of VP-16-213 (NSC 141540, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside).
Hansen M; Hirsch F; Dombernowsky P; Hansen HH
Cancer; 1977 Aug; 40(2):633-7. PubMed ID: 196736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
